29 January 2017

As soon as a tumor becomes hypoxic (deficient in oxygen), it changes its metastasis strategy: instead of producing long strands of connected cells, the tumor produces single cells that move through the body.

In experiments with cancer cells from humans and mice, Peter Friedl, theme Cancer development and immune defense and Steffi Lehmann of ETH Zurich discovered that the cell protein HIF-1 plays a key role in this process. The study provides new insight into how cancer spreads in the body and will be published in the February issue of Current Biology.

A metastasizing tumor has several options. It can disseminate by forming strands that grow into the naturally occurring spaces in the surrounding tissues. This is known as the collective program. But the tumor may also produce individual cells that live independently, which can spread through the bloodstream. For a long time it was unclear how the tumor makes the ‘decision’ to shift from a collective program to the individual-cell program. The research team, led by Peter Friedl and Steffi Lehmann, has discovered a major trigger for this transition: hypoxia. 

Hypoxic conditions
The researchers grew various types of cancer cells from humans and mice in the lab under normal conditions (21 percent oxygen) and hypoxic conditions (0.2 percent oxygen). Under normal conditions, the tumor produced strands of cells, and only a few individual cells escaped. Under hypoxic conditions, many more individual cells were released. In terms of shape and characteristics, these individual cells are similar to leukocytes, a type of white blood cell. Peter Friedl: “Hypoxia not only encourages cell migration, but also affects how the cells migrate.” 

Escape signal
Hypoxia is a normal phenomenon in tumors. A growing tumor is actually not connected to the blood vessels, which means the cancer cells may not have enough oxygen. To continue to grow, the tumor needs to generate blood vessels. This process is called angiogenesis. The cell protein HIF-1, which affects the transcription (reading) of DNA, plays an important role in angiogenesis. But it now appears that HIF-1 is also important for the transition in metastasis program. Suppression of HIF-1 in the cancer cells in the laboratory shifted the individual-cell program back to the collective (branching) program. 

A dandelion that has gone to seed
It is likely that the individual-cell program helps the tumor to metastasize over a greater distance. In fact, the metastasizing tumor cell uses a similar strategy to that of white blood cells. Although the researchers found no evidence that individual-cell metastases were more effective in colonizing organs in the body, once a location was colonized, the cells grew into new tumors more quickly. Peter Friedl: “Hypoxia in tumors is an important mechanism that temporarily causes a rapid increase in the number of metastatic cells. You could compare it to blowing on a dandelion that has gone to seed.”

undefined

Image: tumor strands (blue cells) from which individual cells become detached.
Photograph: Steffi Lehmann and Peter Friedl

 

Related news items


NWO open call GROOT grant for Peter Friedl

24 February 2020 Peter Friedl, theme Cancer development and immune defense, received a 300,000 EUR grant within the NWO-GROOT consortium "Active matter of cancer metastasis" to identify the mechanisms of collective metastasis in breast cancer. read more

p120-catenin-dependent collective brain infiltration by glioma cell networks

7 January 2020 Pavlo Gritsenko and Peter Friedl, theme Cancer development and immune defense, report in Nature Cell Biology, that glioma cells infiltrate the brain by a collective network mechanism, which critically depends on p120 catenin. p120 thus represents a potential target to combat glioma. read more

Collective cancer invasion forms an integrin-dependent radioresistant niche

29 October 2019 Anna Häger and Peter Friedl, theme Cancer development and immune defense, identified a new niche of cancer cell survival and developed an integrin inhibition therapy to overcome resistance. They have published their results in JEM. read more

Three VIDI grants for RIMLS researchers

24 May 2019 Matthijs Jore, Daniele Tauriello and Johannes Textor are each to receive up to 800,000 euros to develop an innovative research theme and to build up their own research group. NWO is awarding the Vidi grant as part of the Innovational Research Incentives Scheme. read more

RIMLS awards festival Twelve winners

16 January 2019 In 5 categories RIMLS young researchers received an award and bonus during the New Year's drinks. See all photo's. read more

Cancer cell moves like a predator Lévy walk may be the weak spot of cancer cells

19 November 2018 In contrast to their non-metastatic counterparts, metastatic cancer cells show movement patterns that are also often employed by predators searching for prey. This was shown by an international study on movement patterns of cancer cells published in Nature Communications. read more